buyModerate cluster of 3
Paul S Platkin bought $250k of Corient Registered Alternatives Fund
President at Corient Registered Alternatives Fund. 25,000 shares at an average of $10.00, traded Feb 3, 2025, filed Feb 3, 2025.
Conviction score
56Value
$250k
25,000 shares
Holdings after
25,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RolePresident
- +13Trade size$250k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000898432-25-000081, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 3, 2025 | POpen-market purchase Common shares of beneficial interest | +25,000 | $10.00 | $250k | 25,000 | Feb 3, 2025 |
Related signals
Other insiders at Corient Registered Alternatives Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | -buy Corient Registered Alternatives Fund | George W Morriss director | $50k 4,673 shares | +92% | |
| 41Moderate | -buy Corient Registered Alternatives Fund | George W Morriss director | $500k 50,000 shares | - | |
| 52Moderate | -buy 3 Corient Registered Alternatives Fund | Alexander Adair Treasurer | $50k 5,000 shares | - | |
| 48Moderate | -buy 3 Corient Registered Alternatives Fund | Matthew E. Forstenhausler director | $100k 10,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.